Yixintang Pharmaceutical Group Dividends and Buybacks
Dividend criteria checks 5/6
Yixintang Pharmaceutical Group is a dividend paying company with a current yield of 2.87%.
Key information
2.9%
Dividend yield
0.04%
Buyback Yield
| Total Shareholder Yield | 2.9% |
| Future Dividend Yield | 3.6% |
| Dividend Growth | 10.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.400 |
| Payout ratio | 153% |
Recent dividend and buyback updates
Recent updates
Calculating The Fair Value Of Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727)
Dec 12
Yixintang Pharmaceutical Group (SZSE:002727) Might Be Having Difficulty Using Its Capital Effectively
Nov 22Yixintang Pharmaceutical Group's (SZSE:002727) Soft Earnings Are Actually Better Than They Appear
Nov 06Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings
Sep 25These 4 Measures Indicate That Yixintang Pharmaceutical Group (SZSE:002727) Is Using Debt Reasonably Well
Jul 15Some Investors May Be Worried About Yixintang Pharmaceutical Group's (SZSE:002727) Returns On Capital
Jun 29Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Intrinsic Value Is Potentially 26% Below Its Share Price
Jun 13Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings Pushing Shares 27% Lower
Jun 13Yixintang Pharmaceutical Group (SZSE:002727) Is Due To Pay A Dividend Of CN¥0.40
May 27Yixintang Pharmaceutical Group's (SZSE:002727) Conservative Accounting Might Explain Soft Earnings
May 03Investors Holding Back On Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727)
Apr 15Return Trends At Yixintang Pharmaceutical Group (SZSE:002727) Aren't Appealing
Mar 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 002727's dividends per share have been stable in the past 10 years.
Growing Dividend: 002727's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Yixintang Pharmaceutical Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (002727) | 2.9% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Consumer Retailing) | 1.8% |
| Analyst forecast (002727) (up to 3 years) | 3.6% |
Notable Dividend: 002727's dividend (2.87%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).
High Dividend: 002727's dividend (2.87%) is in the top 25% of dividend payers in the CN market (2.07%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (153.3%), 002727's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (13.3%), 002727's dividend payments are thoroughly covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 06:00 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yixintang Pharmaceutical Group Co., Ltd. is covered by 20 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Haigang Chen | China International Capital Corporation Limited |
| Feifei Xu | China Merchants Securities Co. Ltd. |
| Bing Zhao | China Renaissance Securities |